Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Risk Factors for Hospitalization, Mechanical Ventilation, or Death Among 10 131 US Veterans With SARS-CoV-2 Infection
George N. Ioannou, Emily R. Locke, Pamela Green, et al.
JAMA Network Open (2020) Vol. 3, Iss. 9, pp. e2022310-e2022310
Open Access | Times Cited: 364

Showing 1-25 of 364 citing articles:

Risk factors for severe and critically ill COVID‐19 patients: A review
Yadong Gao, Mei Ding, Xiang Dong, et al.
Allergy (2020) Vol. 76, Iss. 2, pp. 428-455
Open Access | Times Cited: 1282
Disparities in COVID-19 Outcomes by Race, Ethnicity, and Socioeconomic Status
Shruti Magesh, Daniel John, Wei Tse Li, et al.
JAMA Network Open (2021) Vol. 4, Iss. 11, pp. e2134147-e2134147
Open Access | Times Cited: 569
A systematic review of racial/ethnic and socioeconomic disparities in COVID-19
Ahmad Khanijahani, Shabnam Iezadi, Kamal Gholipour‎, et al.
International Journal for Equity in Health (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 402
COVID-19 and liver disease: mechanistic and clinical perspectives
Thomas Marjot, Gwilym J. Webb, A. Sidney Barritt, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 18, Iss. 5, pp. 348-364
Open Access | Times Cited: 334
Outcomes and Risk Factors Associated With SARS-CoV-2 Infection in a North American Registry of Patients With Multiple Sclerosis
Amber Salter, Robert J. Fox, Scott D. Newsome, et al.
JAMA Neurology (2021) Vol. 78, Iss. 6, pp. 699-699
Open Access | Times Cited: 264
Diabetes, obesity, metabolism, and SARS-CoV-2 infection: the end of the beginning
Daniel J. Drucker
Cell Metabolism (2021) Vol. 33, Iss. 3, pp. 479-498
Open Access | Times Cited: 239
Risk Factors Associated With All-Cause 30-Day Mortality in Nursing Home Residents With COVID-19
Orestis A. Panagiotou, Cyrus M. Kosar, Elizabeth M. White, et al.
JAMA Internal Medicine (2021) Vol. 181, Iss. 4, pp. 439-439
Open Access | Times Cited: 200
Health outcomes and economic burden of hospitalized COVID-19 patients in the United States
Manuela Di Fusco, Kimberly M. Shea, Jay Lin, et al.
Journal of Medical Economics (2021) Vol. 24, Iss. 1, pp. 308-317
Open Access | Times Cited: 189
CT of Post-Acute Lung Complications of COVID-19
Joshua J. Solomon, B. Heyman, Jane P. Ko, et al.
Radiology (2021) Vol. 301, Iss. 2, pp. E383-E395
Open Access | Times Cited: 175
Diabetes, hypertension, body mass index, smoking and COVID-19-related mortality: a systematic review and meta-analysis of observational studies
Yahya Mahamat‐Saleh, Thibault Fiolet, Mathieu E. Rebeaud, et al.
BMJ Open (2021) Vol. 11, Iss. 10, pp. e052777-e052777
Open Access | Times Cited: 164
Life-Threatening COVID-19: Defective Interferons Unleash Excessive Inflammation
Qian Zhang, Paul Bastard, Alexandre Bolze, et al.
Med (2020) Vol. 1, Iss. 1, pp. 14-20
Open Access | Times Cited: 148
Immunology of SARS-CoV-2 infection in children
Janet Chou, Paul G. Thomas, Adrienne G. Randolph
Nature Immunology (2022) Vol. 23, Iss. 2, pp. 177-185
Open Access | Times Cited: 141
Association of Obesity With COVID-19 Severity and Mortality: An Updated Systemic Review, Meta-Analysis, and Meta-Regression
Romil Singh, Sawai Singh Rathore, Hira Khan, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 136
COVID–19 and chronic kidney disease: an updated overview of reviews
Sara S. Jdiaa, Razan Mansour, Abdallah El Alayli, et al.
Journal of Nephrology (2022) Vol. 35, Iss. 1, pp. 69-85
Open Access | Times Cited: 121
Effectiveness of COVID-19 Treatment With Nirmatrelvir–Ritonavir or Molnupiravir Among U.S. Veterans: Target Trial Emulation Studies With One-Month and Six-Month Outcomes
Kristina L. Bajema, Kristin Berry, Elani Streja, et al.
Annals of Internal Medicine (2023) Vol. 176, Iss. 6, pp. 807-816
Open Access | Times Cited: 70
Ethnic inequalities in COVID-19 infection, hospitalisation, intensive care admission, and death: a global systematic review and meta-analysis of over 200 million study participants
Patricia Irizar, Daniel Pan, Dharmi Kapadia, et al.
EClinicalMedicine (2023) Vol. 57, pp. 101877-101877
Open Access | Times Cited: 55
Obesity as an independent risk factor for COVID-19 severity and mortality
Borna Tadayon Najafabadi, Daniel Rayner, Kamyar Shokraee, et al.
Cochrane library (2023) Vol. 2023, Iss. 6
Open Access | Times Cited: 40
COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2·57 million people in Scotland (EAVE II): a prospective cohort study
Utkarsh Agrawal, Srinivasa Vittal Katikireddi, Colin McCowan, et al.
The Lancet Respiratory Medicine (2021) Vol. 9, Iss. 12, pp. 1439-1449
Open Access | Times Cited: 100
COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology
Manel Puig‐Domingo, Mónica Marazuela, Bülent Okan Yıldız, et al.
Endocrine (2021) Vol. 72, Iss. 2, pp. 301-316
Open Access | Times Cited: 99
Risk Factors Associated With SARS-CoV-2 Infections, Hospitalization, and Mortality Among US Nursing Home Residents
Hemalkumar B. Mehta, Shuang Li, James S. Goodwin
JAMA Network Open (2021) Vol. 4, Iss. 3, pp. e216315-e216315
Open Access | Times Cited: 96
COVID-19-associated acute respiratory distress syndrome (CARDS): Current knowledge on pathophysiology and ICU treatment – A narrative review
Carmen A. Pfortmueller, Thibaud Spinetti, Richard D. Urman, et al.
Best Practice & Research Clinical Anaesthesiology (2020) Vol. 35, Iss. 3, pp. 351-368
Open Access | Times Cited: 95
Childhood asthma outcomes during the COVID‐19 pandemic: Findings from the PeARL multi‐national cohort
Nikolaos G. Papadopoulos, Alexander G. Mathioudakis, Adnan Čustović, et al.
Allergy (2021) Vol. 76, Iss. 6, pp. 1765-1775
Open Access | Times Cited: 83
Chronic Diseases as a Predictor for Severity and Mortality of COVID-19: A Systematic Review With Cumulative Meta-Analysis
Jinsong Geng, Xiaolan Yu, Haini Bao, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 83
Hypertension, a Moving Target in COVID-19
Carmine Savoia, Massimo Volpe, Reinhold Kreutz
Circulation Research (2021) Vol. 128, Iss. 7, pp. 1062-1079
Open Access | Times Cited: 78
Cirrhosis and Severe Acute Respiratory Syndrome Coronavirus 2 Infection in US Veterans: Risk of Infection, Hospitalization, Ventilation, and Mortality
George N. Ioannou, Peter S. Liang, Emily R. Locke, et al.
Hepatology (2020) Vol. 74, Iss. 1, pp. 322-335
Open Access | Times Cited: 77
Page 1 - Next Page

Scroll to top